Abstract
AIM
To investigate the effect of lacidipine, thiamine pyrophosphate (TPP) and the combination of lacidipine and TPP against oxidative and inflammatory eye damage induced by bilateral common carotid artery ligation in rats.
METHODS
Male albino Wistar rats were categorized as those who underwent sham surgery (SG), right and left common carotid cross-clamping and unclamping procedure (CCU), lacidipine+CCU (LCCU), TPP+CCU (TCCU), and combination of lacidipine and TPP (LTC)+CCU (LTCCU). One hour before anesthesia, the LCCU (n=6) received lacidipine (4 mg/kg, orally) and the TCCU (n=6) received TPP (20 mg/kg, intraperitoneally). The SG (n=6) and CCU (n=6) received the same volume of distilled water from the same route. After anesthesia (60 mg/kg ketamine, intraperitoneally), the necks of the rats were opened in the midline. Ischemia was created for 10min by placing clips on the right and left common carotid arteries. Rats in the SG only underwent subcutaneous incision. After 10min, the clips were removed and reperfusion was achieved for six days. Then, the animals were euthanized (120 mg/kg ketamine, intraperitoneally) and the levels of oxidant, antioxidant and proinflammatory cytokines in the eye tissues were determined. The retinal tissue of the eye was also examined histopathologically.
RESULTS
Lacidipine, TPP, and LTC significantly prevent the increase in malondialdehyde, tumor necrosis factor-alpha, interleukin-1β (IL-1β), and IL-6 levels, decrease in total glutathione levels, superoxide dismutase and catalase activities and histopathological retinal damage in eye tissue induced by bilateral common carotid artery ligation in rats. The impact of these drugs on protection is determined to be LTC>lacidipine>TPP.
CONCLUSION
As a result of the study, it is concluded that LTC may be more effective than lacidipine and TPP alone in treating ocular ischemic syndrome.
Keywords: ocular ischemic syndrome, lacidipine, thiamine pyrophosphate, oxidative stress
INTRODUCTION
Diseases that cause total or subtotal occlusion of the carotid artery play a significant role in the development of ischemia in the eye. Symptoms of visual impairment accompanying subtotal or total occlusion of the carotid artery are referred to as ocular ischemic syndrome (OIS)[1]. The incidence of OIS is especially high in patients with insufficient collateral circulation between the right and left internal carotid arteries or between the internal and external carotid arteries[1]. The etiology of OIS may be attributed to atherosclerosis, dissecting aneurysms of carotid vessels, Takayasu arteritis, and Behçet's disease[2]. A retinal hypoperfusion injury is a pathophysiological basis for OIS, which often results in severe vision loss[3]. An occlusion of both carotid arteries in animals causes oxidative stress in the retina. There has also been a focus on the fact that oxidant levels increase, and antioxidant levels decrease in the retina[4]. Ischemia-reperfusion (I/R)-induced retinal cell damage is attributed to several mechanisms, including energy deficiency, an increase in intracellular calcium, the generation of free radicals, and an increase in proinflammatory cytokines[5].
A voltage-operated L-type calcium channel blocker, vasoselective and antihypertensive, lacidipine was examined in this study regarding its effects on retinal I/R damage[6]–[7]. Lacidipine has been reported to have a protective effect on organs and tissues by inhibiting lipid peroxidation (LPO) reactions and glutathione depletion[7]. Furthermore, lacidipine has been experimentally demonstrated to have anti-inflammatory properties. The anti-inflammatory effect of lacidipine is attributed to its inhibition of proinflammatory cytokines[8].
Thiamine pyrophosphate (TPP) was another drug we investigated for its effect on retinal I/R damage. TPP is the active metabolite of thiamine[9]. It has been stated in the literature that TPP protects ovarian tissue by inhibiting the increase in oxidant and proinflammatory parameters[10]. It appears that lacidipine and TPP may be effective in the treatment of retinal I/R damage, based on the information. Also, the combination of lacidipine and TPP (LTC) may be more effective in treating retinal I/R damage than either agent alone. It was hence the purpose of this study to investigate biochemically the effects of lacidipine, TPP, and LTC against oxidative and inflammatory eye damage induced by bilateral common carotid artery ligation in rats, as well as to examine retinal tissue histopathologically.
MATERIALS AND METHODS
Ethical Approval
Experiments were carried out in the laboratories of the Experimental Animal Application and Research Centre of Erzincan Binali Yıldırım University. The experiment was performed after approval from the local Animal Experiments Ethics Committee of Erzincan Binali Yildirim University (Date: 30/03/2023, Decision No: 03/06 Number: E-85748827-050.06.04-252336).
Animals
Thirty male Albino Wistar rats, as defined in the experimental design, were provided by the Experimental Animals Application and Research Centre of Erzincan Binali Yıldırım University. The experimental animals were housed and fed for 1wk at a temperature of (22°C±2°C) and a 12-hour light/dark regime to facilitate their adaptation to the environment.
Chemical Substances
Ketamine was procured from Pfizer Drugs Ltd. Sti (Turkey), TPP was procured from BioPharma (Russia), lacidipine was procured from Glaxo Smith Kline Drugs (Turkey) and and sevoflurane liquid 100% was procured from AbbVie (Turkey).
Animal Groups
The experimental animals were created (6 rats per group) as those who underwent sham surgery (SG), right and left common carotid cross-clamping and unclamping (CCU), lacidipine+CCU (LCCU), TPP+CCU (TCCU), and LTC+CCU (LTCCU).
Surgical and Pharmacological Procedures
Surgery was performed under sterile conditions in the laboratory. Before anesthesia 1h, lacidipine (4 mg/kg) was administered orally to the LCCU and LTCCU. Lacidipine has been previously used at these doses in experimental rat studies[11]. Mennini et al[12] also demonstrated that lacidipine reached the cerebral cortex 1h after oral administration in rats. TPP (20 mg/kg) was applied intraperitoneally (ip) in the TCCU and LTCCU. TPP at these doses has been previously used in a brain I/R model in rats[13]. In addition, it has been demonstrated that TPP administered 1h before the cerebral hypoxia model procedure in rats crosses the blood brain barrier and reaches the brain and has a healing effect[14]. With the same method, the same amount of distilled water was applied to the SG and CCU groups. This treatment procedure continued for 6d, 1 time per day. Ketamine hydrochloride (60 mg/kg, ip) was used for general anesthesia. Sevoflurane 3% was used at appropriate intervals to maintain anaesthesia. During this period, all rats were immobilized on an operating table in the supine position and their necks were shaved midline. Following disinfection, an incision was made in the midline. A superficial microdissection was followed by deep microdissection of the right and left common carotid arteries. During this procedure, the trachea was visualized, the paratracheal muscles were dissected, the common carotid artery was reached, and a clip was placed on the artery. For 10min, the clips were kept closed to create ischemia. The rats in SG received a subcutaneous incision but no clamping. The ischemia period was followed by the removal of clips, suturing of the incisions, and reperfusion for six days. Then, the animals were euthanized with ketamine (120 mg/kg, ip) and malondialdehyde (MDA), total glutathione (tGSH), superoxide dismutase (SOD), catalase (CAT), tumor necrosis factor-alpha (TNF-α), interleukin-1β (IL-1β) and IL-6 were measured in removed eye tissues. The retinal tissue of the eye was also examined histopathologically.
Biochemical Analyses
MDA, tGSH, SOD, CAT, and protein analyses
After washing with physiological saline, tissue samples were crushed by adding liquid nitrogen and homogenized. Supernatants were used for MDA, tGSH, SOD, and protein analysis. The determination of MDA (nmol/mg protein), tGSH (nmol/mg protein), and SOD (U/mg protein) enzyme-linked immunosorbent assay in eye tissues was performed according to the instructions provided with each assay kit (Cayman Chemical Company, product No. 10009055, 703002, and 706002, respectively). The CAT (U/mg protein) was determined using the method proposed by Góth[15].
TNF-α, IL-1β, and IL-6 analyses
Tissues to be analyzed were first weighed. It was then frozen with liquid nitrogen and homogenized in air with a pestle and kept at 2°C-8°C. Phosphate-buffered saline (pH 7.4) was added at a ratio of 1/10 (w/v) and centrifuged (20min, 10 000 rpm). The supernatant portion was taken for analysis. TNF-α (ng/L), IL-1β (pg/L), and IL-6 (ng/L) levels were measured using enzyme-linked immunosorbent assay kits supplied by Eastbiopharm Co. Ltd., China.
Histopathological Examination
All eye tissue samples were kept in 10% formaldehyde solution for 72h for light microscopy evaluation. Later, the samples were taken into cassettes and kept under running water for 24h. It was then treated with graded alcohol (60%-100%) for dehydration. Eye tissues were made transparent using xylol and then placed in paraffin. Sections (4-5 µm) were obtained from paraffin blocks and stained with hematoxylin-eosin. At this stage, 100 serial sections were taken from paraffin blocks obtained from the retina tissue close to the optic disc. Counting and scoring were performed in six areas, one central and five peripheral, photographed at 400× magnification in 10 randomly selected sections from 100 serial sections taken. Semiquantitative evaluations were made by 2 blinded histologists and the scores were compared. Photographs were evaluated and photographed under a light microscope at 400× magnification (Olympus® Inc. Tokyo, Japan). Ganglion cell layer (GCL), inner plexiform layer (IPL), inner nuclear layer (INL), outer plexiform layer (OPL), outer nuclear layer (ONL), and photoreceptor layer (PRL) and all layers were calculated using measurement tools of the Olympus DP2-SAL firmware program (Olympus® Inc. Tokyo, Japan). Retinal tissue was evaluated for retinal destruction, edema, vascular congestion, and the presence of polymorphonuclear cells and scored between 0 and 3 (0, no damage; 1, mild; 2, moderate; 3, severe)[16].
Statistical Analysis
Statistical analyses were performed using IBM SPSS Statistics 22 Software. First, the Kolmogorov-Smirnov test was applied to the numerical data. For normally distributed parameters, one-way ANOVA was preferred in the analysis. The selection of post-hoc tests was made according to Levene's test (Tukey HSD or Games-Howell) and data were presented as mean value±standard error. Kruskal-Wallis test followed by Dunn's test was used for the analysis of non-normally distributed data and histopathological grading data. Data set was expressed as a median (maximum-minimum). Statistical significance was determined to be 0.05.
RESULTS
Biochemical Findings
MDA, tGSH, SOD, and CAT analysis results
MDA levels in the CCU group were higher than those in healthy rats (P<0.001). In comparison to CCU, MDA levels were lower in LCCU, TCCU, and LTCCU (P<0.001). MDA levels in SG and LTCCU groups were similar (P=0.992). tGSH level, SOD, and CAT activities were lower in the CCU group than in the SG group. This decrease was observed to be inhibited in the LCCU, TCCU, and LTCCU groups that received treatment (P<0.001). In the LTCCU group, tGSH (P=0.951), SOD (P=0.996), and CAT (P=0.821) levels were similar to those in the SG group (Table 1).
Table 1. Analysis results of biochemical data obtained from experimental groups.
| Biochemical parameters | SG | CCU | LCCU | TCCU | LTCCU | F | P |
| MDA (nmol/mg protein) | 2.46±0.10 (0.391)a | 6.35±0.11 (0.083) | 3.27±0.05 (0.412)a | 4.60±0.11 (0.704)a | 2.51±0.07 (0.647)a,b | 444.545 | <0.0001 |
| tGSH (nmol/mg protein) | 5.39±0.09 (0.641)a | 1.73±0.04 (0.708) | 4.27±0.05 (0.841)a | 3.13±0.03 (0.490)a | 5.32±0.10 (0.837)a,b | 531.224 | <0.0001 |
| SOD (U/mg protein) | 8.52±0.09 (0.513)a | 3.40±0.07 (0.869) | 7.27±0.04 (0.884)a | 6.13±0.03 (0.751)a | 8.49±0.08 (0.599)a,b | 1038.718 | <0.0001 |
| CAT (U/mg protein) | 7.49±0.05 (0.059)a | 3.11±0.03 (0.404) | 6.18±0.05 (0.525)a | 5.10±0.05 (0.600)a | 7.41±0.08 (0.426)a,b | 1183.098 | <0.0001 |
| TNF-α (ng/L) | 1.55±0.06 (0.943)a | 5.21±0.03 (0.021) | 2.62±0.06 (0.491)a | 3.60±0.08 (0.735)a | 1.60±0.08 (0.897)a,b | 637.985 | <0.0001 |
| IL-1β (pg/L) | 1.23±0.03 (0.648)a | 5.30±0.05 (0.260) | 2.33±0.04 (0.395)a | 3.38±0.04 (0.425)a | 1.23±0.03 (0.443)a,b | 1899.326 | <0.0001 |
| IL-6 (ng/L) | 2.52±0.06 (0.682)a | 5.88±0.03 (0.550) | 3.59±0.06 (0.133)a | 4.72±0.05 (0.437)a | 2.56±0.07 (0.371)a,b | 759.998 | <0.0001 |
aP<0.001 vs CCU, bP>0.05 vs SG. Statistical analysis was done with one way ANOVA. Games-Howell test or Tukey HSD was applied as post hoc. SE: Standard error; MDA: Malondialdehyde; tGSH: Total glutathione; SOD: Superoxide dismutase; CAT: Catalase; TNF-α: Tumor necrosis factor-alpha; IL: Interleukin 1β; SG: Sham surgery group; CCU: Right and left common carotid cross-clamping and unclamping; LCCU: Lacidipine+CCU; TCCU: Thiamine pyrophosphate+CCU; LTCCU: Lacidipine+TCCU.
mean±SE (Shapiro Wilk test-significance)
TNF-α, IL-1β and IL-6 analysis results
TNF-α, IL-1β, and IL-6 levels were found to be higher in the CCU group than in sham operation-applied rats (P<0.001). TNF-α, IL-1β, and IL-6 levels were found to be lower in LCCU, TCCU, and LTCCU groups than in CCU group (P<0.001). There was no significant difference between SG and LTCCU groups in terms of TNF-α, (P=0.980), IL-1β (P=1.000), and IL-6 (P=0.991; Table 1).
Histopathologic Findings
As shown in Figure 1A, Table 2, the retina of the SG group had a normal histological appearance. An examination was conducted of the GCL, IPL, INL, OPL, ONL, and PRL and all layers were clearly defined. The nuclei of the INL and ONL were stained with a basophilic stain. A limited number of blood capillaries were observed in the GCL and the IPL.
Figure 1. Retinal tissues of the experimental groups.
A: Retinal tissue of the SG group; B: Retinal tissue of the CCU; C: Retinal tissue of the LCCU; D: Retinal tissue of the TCCU; E: Retinal tissue of the LTCCU. Arrow: Polymorphonuclear cell; Star: Dilated and congested blood capillary; Arrowhead: Vacuolization areas; E: Edema; GCL: Ganglion cell layer; IPL: Inner plexiform layer; INL: Inner nuclear layer; OPL: Outer plexiform layer; ONL: Outer nuclear layer; PRL: Photoreceptor layer; SG: Sham surgery group; CCU: Right and left common carotid cross-clamping and unclamping; LCCU: Lacidipine+CCU; TCCU: Thiamine pyrophosphate+CCU; LTCCU: Lacidipine+TCCU (HE×400).
Table 2. Analysis results of histopathological evaluation data obtained from experimental groups.
| Histopathological parameters | SG | CCU | LCCU | TCCU | LTCCU | F or H | P |
| Histopatological grading | |||||||
| Retinal destruction1 | 0a | 3 (2-3) | 1 (0-2)a | 1 (1-3)a | 0 (0-2)a,b | 135.422 | <0.0001 |
| Edema1 | 0a | 3 (2-3) | 1 (0-2)a | 1 (0-3)a | 0 (0-2)a,b | 132.317 | <0.0001 |
| Vascular congestion1 | 0a | 3 (2-3) | 0 (0-1)a,b | 1 (0-3)a | 0 (0-2)a,b | 136.271 | <0.0001 |
| Polymorphonuclear cell infiltration1 | 0a | 2 (1-3) | 0 (0-1)a,b | 1 (0-3)a | 0 (0-2)a,b | 129.575 | <0.0001 |
| Retina thIckness of layers (µm) | |||||||
| Inner plexiform layer2 | 109.72±0.79a | 163.12±1.27 | 120.88±0.88a | 136.43±1.53a | 112.74±0.76a,b | 402.349 | <0.0001 |
| Inner nuclear layer2 | 120.48±1.10a | 157.49±1.22 | 127.02±0.73a | 136.82±1.19a | 121.91±1.70a,b | 200.655 | <0.0001 |
| Outer nuclear layer1 | 163.95 (142.60-186.90)a | 242.60 (216.40-258.10) | 191.65 (180.90-199.40)a | 217.55 (205.60-241.60)c | 171.35 (154.20-189.10)a,b | 164.078 | <0.0001 |
| Total retina1 | 655.25 (623.50-680.20)a | 780.95 (731.90-819.00) | 712.60 (708.60-722.60)a | 743.85 (719.50-760.60)c | 672.80 (663.20-691.00)a,b | 167.622 | <0.0001 |
| Number of ganglion cells in the ganglion cell layer | 8 (7-9)a | 5 (4-6) | 6 (5-7)a | 6 (5-6)c | 8 (7-9)a,b | 142.985 | <0.0001 |
aP<0.05 vs CCU; bP>0.05 vs SG; cP>0.05 vs CCU. 1Kruskal-Wallis test, Dunn's test, median (maximum-minimum); 2One way ANOVA, Tukey HSD or Games-Howell test, mean±standard error. SG: Sham surgery group; CCU: Right and left common carotid cross-clamping and unclamping; LCCU: Lacidipine+CCU; TCCU: Thiamine pyrophosphate+CCU; LTCCU: Lacidipine+TCCU.
In the retinal tissue of the CCU group, severe degenerative changes were identified with a damage severity grade of 3. There were significant reductions in ganglion cells in some samples, resulting from a disordered distribution of ganglion cells. Several changes in retinal blood vessel walls were observed, including thickening of the walls, dilatation, and congestion. There was intense edema in the GCL, as well as the remarkable presence of polymorphonuclear cells. In this group, the PRL had a foamy appearance and several areas of vacuolization were present. Observations indicated that there was significant degeneration and separation of the OPL, as well as irregular groupings of nuclei in the INL and ONL. OPL was thin and appeared to be degenerating. There were numerous void areas observed in INL (Figure 1B, Table 2).
In retinal tissue sections from the LCCU group with a damage severity of grade 1, irregularities in the GCL were reduced compared to those in the CCU, however edematous areas persisted in some samples. Comparing the INL and ONL, it was determined that the number of voids and irregularities between cells was significantly reduced as compared to the CCU. The appearance of bubbles in the PRL almost disappeared and vacuolization was significantly reduced (Figure 1C, Table 2).
There was edema in the GCL of the retinal tissue of the TCCU group with a grade-1 degree of damage severity, congestion in the capillaries, and polymorphonuclear cells near the capillaries. A slight segmental fragmentation was observed in the PRL. As compared to the healthy group, the INL nucleus density was relatively decreased. Cell separation and moderate deterioration of connections were observed in the OPL. An overall image of the retina revealed mild edema (Figure 1D, Table 2).
The retinal tissues of the LTCCU group, with grade 0 damage severity, appeared to be similar to those of the healthy group, and the retinal layers appeared normal. The retinal blood capillaries had a normal appearance, and no polymorphonuclear cells were found. In both the inner and ONL, the nuclei of the cells were more organized, ordered, and of a higher density than those of the damaged groups. Damaged groups also showed a reduced separation of the OPL and exhibited a similar appearance to healthy groups. PRL was identical to that of the healthy group (Figure 1E, Table 2).
DISCUSSION
In the current study, the effect of lacidipine, TPP, and LTC on experimentally induced OIS in rats was investigated biochemically, and the retinal tissues were examined histopathologically. According to the literature, excessive levels of reactive oxygen species (ROS) produced by mitochondria during the reperfusion process after ischemia may result in oxidative stress[12]. In biological membranes, ROS produced during I/R reacted with unsaturated fats to produce MDA, the end product of LPO[17]–[18]. In addition to being a biological marker of tissue damage, MDA was also one of the most important markers of oxidative damage[19]–[20]. In this study, it was revealed that there was a significant increase in MDA level in the eye tissue of the I/R group compared to the control group. It was reported in previous studies that ROS production in the retinal tissue increased as a result of I/R, inducing LPO and ultimately causing oxidative damage[19].
On the other hand, lacidipine, TPP, and LTC were found to significantly inhibit the increase in MDA levels in the eye tissue induced by I/R. Nevertheless, LTC treatment reduced the LPO reaction intensity to the highest level and brought it closer to the levels observed in the control group. In the literature, there was no information on the possible effects of lacidipine and TPP on MDA levels in the retina following I/R injury. However, it was reported by Khurana et al[7] that lacidipine exerted an antioxidant effect by preventing the increase in LPO in brain tissue. Cinici et al[21] reported that TPP protected the retina of the eye from oxidative damage associated with hyperglycemia by suppressing the production of MDA. On the other hand, it has been reported in the literature that LPO is increased in diabetic cataract lenses and serum MDA levels are increased in patients with diabetic cataract. The potential benefit of lasidipine, TPP and LTC in diabetic cataract is an open field to be studied[22].
As is well known, endogenous antioxidants contributed significantly to the removal of ROS formed during I/R[23]. Therefore, in our study, the level of tGSH, an endogenous antioxidant, was measured. GSH protects the cell against ROS damage[24]. A decrease in GSH levels as a result of I/R was reported to be associated with an increase in LPO in the literature[17]. Wu et al[25] showed that there was a significant decrease in GSH levels in the retinal tissue of rats subjected to I/R, in parallel with the increase in oxidants, compared to the control group. In this study, tGSH levels were significantly decreased in the eye tissue of rats as a result of I/R injury, as has been reported in the literature. LTC, as examined in terms of its ability to prevent oxidative damage, prevented tGSH reduction in eye tissue more significantly than lacidipine or TPP treated alone. In the literature, no information was available regarding the possible effects of lacidipine, TPP, or LTC on tGSH levels in the eye tissue following an I/R injury. There was, however, evidence that lacidipine exerted a protective effect by inhibiting the decrease in GSH in brain tissue[26]. Additionally, literature indicated that TPP protected the retina from oxidative damage associated with hyperglycemia by inhibiting the reduction of tGSH[21].
SOD was another endogenous antioxidant that decreased in the eye tissue of experimental animals as a result of I/R in this study. SOD has been known to reduce superoxide radicals and produce hydrogen peroxide[27]. In contrast, the CAT enzyme prevented the accumulation of hydrogen peroxide[24]. Our biochemical findings revealed that the antioxidant systems in the I/R group were insufficient to neutralize ROS. In the literature, it has been shown that endogenous antioxidant enzymes increase after the increase in ROS in the experimental retinal I/R model[17].
As a result of this study, lacidipine, and TTP significantly inhibited the decrease in SOD and CAT enzyme activity in the eye tissue after I/R, and the activity of these enzymes was the highest in the LTC-applied rats. No other studies examined the effects of lacidipine on SOD and CAT enzymes in eye tissue. However, the role of SOD and CAT enzyme levels in lacidipine's protective effect was proven[28]. Some studies associated the protective effect of TPP on retinal tissue with SOD and other enzymatic antioxidants[21].
It is known that the increase in calcium ion concentration in retinal I/R pathophysiology is associated with the increase in the production of proinflammatory cytokines[29]. TNF-α was a major inflammatory mediator of neuronal death after ischemic damage to the retina[30]. Studies show that increased proinflammatory cytokines accelerate the inflammatory process and ultimately negatively affect neuronal survival after retinal I/R[31]. A significant increase was observed in TNF-α, IL-1β, and IL-6 levels in the eye tissues of rats in the I/R-mediated OIS model. These findings were consistent with those obtained in the studies conducted by Wang et al[32]. LTC prevented the increase of TNF-α, IL-1β, and IL-6 in I/R treated eye tissue more significantly than lacidipine and TPP treated alone. No studies were found in the literature on lacidipine's effects on proinflammatory cytokine levels in eye tissue. However, Karakus et al[11] reported that inflammation induced by serum TNF-α, IL-1β, and IL-6 levels were suppressed as a result of lacidipine treatment. It was documented that TPP suppressed the increase of TNF-α, and IL-1β in the optic nerve tissue and protected the optic nerve from cytokine damage[33]. Kundu et al[34] found that suppression of cytokines such as TNF-α, IL-1β and IL-6 decreased ocular surface inflammation and symptoms in dry eye disease. Oxidative stress has also been held responsible for the pathogenesis of dry eye disease[35]. Lacidipine, TPP and especially LTC have the potential to be beneficial for dry eye disease with their antioxidative and anti-inflammatory activities.
Histopathological findings supported the biochemical findings obtained in this study. Histological analysis revealed that I/R caused serious degeneration of retinal tissue, decrease in retinal tissue thickness, dilation of blood vessels, and enlargement of polymorphonuclear cells, as well as edema and vacuolation. These histopathological findings, such as the thinning of retinal tissue and the decrease in ganglion cells, were supported by histopathological findings in rats with OIS[4],[36]. An et al[37] found a decrease in total retinal thickness, IPL, INL, and OPL. There was even evidence that OIS caused loss of pupillary reflex and death of retinal ganglion cells and photoreceptors[38]. Our histopathological analysis results support the findings of Cinici et al's[21] study showing that TPP reduces oxidative ocular damage.
In conclusion, bilateral common carotid artery ligation caused an increase in oxidant and proinflammatory cytokines and a decrease in antioxidants in the eye tissue of rats. Additionally, OIS-induced histopathological signs were found in the eye retina. Lacidipine, TPP, and LTC significantly prevented the alteration of oxidant, proinflammatory cytokine, and antioxidant parameters in eye tissue with common carotid artery ligation. Additionally, lacidipine, TPP, and LTC significantly reduced OIS symptoms histopathologically. It was LTC>lacidipine>TPP that inhibited the oxidative and histopathological harm associated with carotid artery ligation the best. The results of our experiments indicated that LTC could be more beneficial than lacidipine and TPP alone in treating OIS. In addition to measuring the total levels of oxidants and antioxidants in the eye tissue, a molecular analysis of the histopathology of the eye tissue was recommended.
Footnotes
Conflicts of Interest: Cicek I, None; Somuncu AM, None; Altuner D, None; Suleyman B, None; Mammadov R, None; Bulut S, None; Coban TA, None; Bal Tastan T, None; Suleyman H, None.
REFERENCES
- 1.Lee D, Tomita Y, Yang LZ, Negishi K, Kurihara T. Ocular ischemic syndrome and its related experimental models. Int J Mol Sci. 2022;23(9):5249. doi: 10.3390/ijms23095249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Vilares-Morgado R, Nunes HMM, Dos Reis RS, Barbosa-Breda J. Management of ocular arterial ischemic diseases: a review. Graefes Arch Clin Exp Ophthalmol. 2023;261(1):1–22. doi: 10.1007/s00417-022-05747-x. [DOI] [PubMed] [Google Scholar]
- 3.Qin YL, Ji MQ, Deng TT, Luo D, Zi YX, Pan L, Wang ZJ, Jin M. Functional and morphologic study of retinal hypoperfusion injury induced by bilateral common carotid artery occlusion in rats. Sci Rep. 2019;9(1):80. doi: 10.1038/s41598-018-36400-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Du R, Wang JL, Wang YL. Role of RhoA/MERK1/ERK1/2/iNOS signaling in ocular ischemic syndrome. Graefes Arch Clin Exp Ophthalmol. 2016;254(11):2217–2226. doi: 10.1007/s00417-016-3456-1. [DOI] [PubMed] [Google Scholar]
- 5.D'Onofrio PM, Koeberle PD. What can we learn about stroke from retinal ischemia models? Acta Pharmacol Sin. 2013;34(1):91–103. doi: 10.1038/aps.2012.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Sai Chebrolu T, Kumar L, Verma R. Lacidipine: review of analytical methods developed for pharmaceutical dosage forms and biological fluids. Bioanalysis. 2021;13(12):1011–1024. doi: 10.4155/bio-2021-0024. [DOI] [PubMed] [Google Scholar]
- 7.Khurana K, Kumar M, Bansal N. Lacidipine attenuates symptoms of nicotine withdrawal in mice. Neurotox Res. 2021;39(6):1920–1936. doi: 10.1007/s12640-021-00421-2. [DOI] [PubMed] [Google Scholar]
- 8.Wang QL, Zhao L, Feng N, et al. Lacidipine attenuates TNF-α-induced cardiomyocyte apoptosis. Cytokine. 2015;71(1):60–65. doi: 10.1016/j.cyto.2014.08.004. [DOI] [PubMed] [Google Scholar]
- 9.Gundogan K, Sahin GG, Ergul SS, et al. Evaluation of whole blood thiamine pyrophosphate concentrations in critically ill patients receiving chronic diuretic therapy prior to admission to Turkish intensive care units: a pragmatic, multicenter, prospective study. J Crit Care. 2023;77:154326. doi: 10.1016/j.jcrc.2023.154326. [DOI] [PubMed] [Google Scholar]
- 10.Ozer M, Ince S, Gundogdu B, Aktas M, Uzel K, Gursul C, Suleyman H, Suleyman Z. Effect of thiamine pyrophosphate on cyclophosphamide-induced oxidative ovarian damage and reproductive dysfunction in female rats. Adv Clin Exp Med. 2022;31(2):129–137. doi: 10.17219/acem/142535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Karakus E, Halici Z, Albayrak A, Bayir Y, Demirci E, Aydin A, Ozturk-Karagoz B, Cadirci E, Ayan AK, Sahin A, Unal D. Effects of administration of amlodipine and lacidipine on inflammation-induced bone loss in the ovariectomized rat. Inflammation. 2016;39(1):336–346. doi: 10.1007/s10753-015-0254-6. [DOI] [PubMed] [Google Scholar]
- 12.Mennini T, Taddei C, Uslenghi A, Cagnotto A, Micheli D, Trist D, Gaviraghi G, Ratti E. In-vivo binding of (+)-[3H]PN 200-110 to peripheral tissues and brain of spontaneously hypertensive rats: effect of lacidipine. J Pharm Pharmacol. 1993;45(5):430–433. doi: 10.1111/j.2042-7158.1993.tb05570.x. [DOI] [PubMed] [Google Scholar]
- 13.Yasar H, Demirdogen F, Suleyman B, Mammadov R, Altuner D, Coban TA, Bulut S, Gursul C, Suleyman H. Effect of thiamine pyrophosphate upon oxidative brain injury induced by ischemia-reperfusion in rats. International J Pharmacology. 2023;19(2):277–285. [Google Scholar]
- 14.Peraza AV, Ávila MAM, Bravo-Luna MÁJ, et al. Thiamine pyrophosphate reduces hypoxia-induced cellular damage in neonatal rat brain. Int Journal Morphol. 2014;3(2):531–536. [Google Scholar]
- 15.Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta. 1991;196(2-3):143–151. doi: 10.1016/0009-8981(91)90067-m. [DOI] [PubMed] [Google Scholar]
- 16.Bancroft JD, Gamble M, editors. Theory and practice of histological techniques. Elsevier health sciences; 2008. [Google Scholar]
- 17.Xu YP, Han F, Tan J. Edaravone protects the retina against ischemia/reperfusion-induced oxidative injury through the PI3K/Akt/Nrf2 pathway. Mol Med Rep. 2017;16(6):9210–9216. doi: 10.3892/mmr.2017.7739. [DOI] [PubMed] [Google Scholar]
- 18.Ren HW, Yu W, Wang YN, Zhang XY, Song SQ, Gong SY, Meng LY, Gan C, Liu BJ, Gong Q. Effects of autophagy inhibitor 3-methyladenine on a diabetic mice model. Int J Ophthalmol. 2023;16(9):1456–1464. doi: 10.18240/ijo.2023.09.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Cherian DA, Peter T, Narayanan A, Madhavan SS, Achammada S, Vynat GP. Malondialdehyde as a marker of oxidative stress in periodontitis patients. J Pharm Bioallied Sci. 2019;11(Suppl 2):S297–S300. doi: 10.4103/JPBS.JPBS_17_19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Xu C, Xu JP, Zhang WL, Zheng FM, Lou XF. Expression of miR-210-3p in the aqueous humor of patients with age-related cataracts and its effect on human lens epithelial cell injury induced by hydrogen peroxide. Arq Bras Oftalmol. 2024;87(5):e2022-0274:1-8. doi: 10.5935/0004-2749.2022-0274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Cinici E, Ahiskali I, Cetin N, Suleyman B, Kukula O, Altuner D, Coban A, Balta H, Kuzucu M, Suleyman H. Effect of thiamine pyrophosphate on retinopathy induced by hyperglycemia in rats: a biochemical and pathological evaluation. Indian J Ophthalmol. 2016;64(6):434–439. doi: 10.4103/0301-4738.187666. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Mishra D, Kashyap A, Srivastav T, Yadav A, Pandey S, Majhi MM, Verma K, Prabu A, Singh V. Enzymatic and biochemical properties of lens in age-related cataract versus diabetic cataract: a narrative review. Indian J Ophthalmol. 2023;71(6):2379–2384. doi: 10.4103/ijo.IJO_1784_22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Nalcacioglu P, Kavuncu S, Taskin Turkmenoglu T, Sonmez CA. The effect of idebenone and corticosteroid treatment on methanol-induced toxic optic nerve and retinal damage in rats: biochemical and histopathological examination. Cutan Ocul Toxicol. 2022;41(3):250–256. doi: 10.1080/15569527.2022.2106994. [DOI] [PubMed] [Google Scholar]
- 24.Ighodaro OM, Akinloye OA. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alex J Med. 2018;54(4):287–293. [Google Scholar]
- 25.Wu IH, Chan SM, Lin CT. The neuroprotective effect of submicron and blended Lycium barbarum for experiment retinal ischemia and reperfusion injury in rats. J Vet Med Sci. 2020;82(11):1719–1728. doi: 10.1292/jvms.19-0646. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Polat B, Suleyman H, Sener E, Akcay F. Examination of the effects of thiamine and thiamine pyrophosphate on Doxorubicin-induced experimental cardiotoxicity. J Cardiovasc Pharmacol Ther. 2015;20(2):221–229. doi: 10.1177/1074248414552901. [DOI] [PubMed] [Google Scholar]
- 27.Zameer R, Fatima K, Azeem F, et al. Genome-wide characterization of superoxide dismutase (SOD) genes in Daucus carota: novel insights into structure, expression, and binding interaction with hydrogen peroxide (H2O2) under abiotic stress condition. Front Plant Sci. 2022;13:870241. doi: 10.3389/fpls.2022.870241. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Kamal S. Nephroprotection of lacidipine against gentamycin-induced nephrotoxicity in albino rats. J Exp Pharmacol. 2010;2:59–63. doi: 10.2147/jep.s10978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Minhas G, Sharma J, Khan N. Cellular stress response and immune signaling in retinal ischemia-reperfusion injury. Front Immunol. 2016;7:444. doi: 10.3389/fimmu.2016.00444. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Jiang N, Li ZD, Li ZH, Zhang YY, Yu ZY, Wan PX, Zhu YT, Li YQ, Su WR, Zhuo YH. Laquinimod exerts anti-inflammatory and antiapoptotic effects in retinal ischemia/reperfusion injury. Int Immunopharmacol. 2020;88:106989. doi: 10.1016/j.intimp.2020.106989. [DOI] [PubMed] [Google Scholar]
- 31.Yang YJ, Wang N, Xu L, Liu YX, Huang LL, Gu MY, Wu Y, Guo WY, Sun H. Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia/reperfusion injury. Cell Death Dis. 2023;14(2):92. doi: 10.1038/s41419-023-05616-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Wang N, Yang YJ, Liu YX, Huang LL, Gu MY, Wu Y, Xu L, Sun H, Guo WY. Magnolol limits NFκB-dependent inflammation by targeting PPARγ relieving retinal ischemia/reperfusion injury. Int Immunopharmacol. 2022;112:109242. doi: 10.1016/j.intimp.2022.109242. [DOI] [PubMed] [Google Scholar]
- 33.Ucak T, Karakurt Y, Tasli G, Cimen FK, Icel E, Kurt N, Ahiskali I, Süleyman H. The effects of thiamine pyrophosphate on ethanol induced optic nerve damage. BMC Pharmacol Toxicol. 2019;20(1):40. doi: 10.1186/s40360-019-0319-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kundu G, Shetty R, D'Souza S, Gorimanipalli B, Koul A, Sethu S. Effect of maqui-berry extract in dry eye disease - A clinical and molecular analysis. Indian J Ophthalmol. 2023;71(4):1613–1618. doi: 10.4103/IJO.IJO_2909_22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Gorimanipalli B, Khamar P, Sethu S, Shetty R. Hormones and dry eye disease. Indian J Ophthalmol. 2023;71(4):1276–1284. doi: 10.4103/IJO.IJO_2887_22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Zhao L, Wang YL, Hong H, Xie GL, Li HY. BuyangHuanwu decoction (BYHWD) protects against retinal ischemic injury. Int J Clin Exp Pathol. 2017;10(9):9177–9189. [PMC free article] [PubMed] [Google Scholar]
- 37.An X, Liu LJ, Bu JP. Changes of retinal morphology and expressions of RhoA and ROCK-2 in ocular ischemic syndrome rats. Shiyan Dongwu Yu Bijiao Yixue. 2020;40(5):397–402. [Google Scholar]
- 38.Stevens WD, Fortin T, Pappas BA. Retinal and optic nerve degeneration after chronic carotid ligation: time course and role of light exposure. Stroke. 2002;33(4):1107–1112. doi: 10.1161/01.str.0000014204.05597.0c. [DOI] [PubMed] [Google Scholar]

